Publication in refereed journal
香港中文大学研究人员 ( 现职)
| 何名熙教授 (麻醉及深切治疗学系) |
全文
| 数位物件识别号 (DOI) http://dx.doi.org/10.1016/j.coph.2012.02.014 |
引用次数
Web of Sciencehttp://aims.cuhk.edu.hk/converis/portal/Publication/0WOS source URL
其它资讯
摘要Renal dysfunction after coronary artery bypass grafting is common and is associated with increased morbidity and mortality. A number of strategies with potential renoprotective effects have been investigated, but no single one has been found to warrant routine use in CABG except fenoldopam in which the data to date appear promising. Other measures such as avoidance of nephrotoxic agents, including recent radiocontrast for coronary angiography, may reduce the incidence of renal dysfunction after cardiac surgery and should be implemented in routine care, whenever possible. The best renal protection strategy remains the same as for other organ protection and consists of optimizing haemodynamics, oxygenation, metabolic states and hydration.
着者Ho AMH, Chan SKC
期刊名称CURRENT OPINION IN PHARMACOLOGY
出版年份2http://aims.cuhk.edu.hk/converis/portal/Publication/012
月份4
日期1
卷号12
期次2
出版社Elsevier
页次181 - 188
国际标準期刊号1471-4892
电子国际标準期刊号1471-4973
语言英式英语
Web of Science 学科类别Pharmacology & Pharmacy; PHARMACOLOGY & PHARMACY
